Obesity-drug developer BioAge jumps nearly 30% while Texas-based Barnett Shale driller BKV posts smaller gain.

BioAge Labs is bringing in almost $200 million via its Nasdaq IPO this morning, with the proceeds earmarked for taking its ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Shares of BioAge Labs opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer against the backdrop of surging investor enthusiasm.

The U.S. IPO market looks stable this week, with a few new companies aiming to raise capital, as the Federal Reserve reduced ...

FrontView REIT Inc., a landlord that focuses on businesses with stores in prominent locations, is seeking to raise $277 million in an initial public offering, joining a clutch of companies aiming to ...